## TRIP: Tripadvisor, Inc. - XLY: Consumer Cyclical

### Executive Summary

No thesis match: MRS_10 -4.8% below STRENGTH zone (3.0-6.0%). Stock is in no-man's land without clear edge. Caution: momentum weakening (-4.6% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($13.04)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 1
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Tripadvisor (TRIP): Reassessing Valuation After Recent Share Price Weakness and Ongoing Profit Growth**
- Source: Simply Wall Street | 20251221T060939 | Bullish | Relevance: 100%
- Tripadvisor's shares have declined recently, but the company continues to show revenue and profit growth, prompting a re-evaluation of its current valuation. The market narrative suggests Tripadvisor is undervalued, with a fair value estimate of $18.16, driven by increased app adoption and AI-powered recommendations leading to higher user engagement and improved margins. However, risks like organic traffic declines and competitive pressures could impact this upside.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-11 | Jefferies | $12 | $13 | -4% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-11 | Jefferies | main | Underperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 3 ($0.08M) |
| Sells | 9 ($0.35M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 58.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 5 |

**Top Holders:**
- Blackrock Inc.: 14.5% (-1.0%)
- Vanguard Group Inc: 10.1% (-6.5%)
- Starboard Value LP: 8.1% (+11.9%)
- Ameriprise Financial: 6.3% (+24.2%)
- State Street Corpora: 4.2% (+5.6%)

### Key Risks

1. Momentum deterioration: MRS_10 falling (-4.6% 5d) with bearish MACD, trend may be turning.
2. High short interest (27.7%, 8.9 days to cover): squeeze risk or crowded bearish bet.
3. Long-term trend broken: trading 7.4% below SMA200.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.05 indicates undervaluation relative to growth. Forward P/E 8.0x attractive for 29% earnings growth. Analyst sentiment negative (1 target cuts vs 0 raises). Institutional flow bullish (4 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $1.7B |
| Beta | 1.01 |
| 52W Range | $10.43 - $20.16 |
| Short Interest | 27.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.05 |
| Forward P/E | 8.0 |
| Current P/E | 10.3 |
| YoY Growth | 29.3% |
| EPS Direction | FALLING |

### Technicals

MRS_10 deteriorating from -0.2% to -4.8% (-4.6% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 7.8pp (needs >3.0% for momentum thesis). Underperforming sector by 6.6pp, stock-specific weakness. Below SMA200 (0.93x), long-term trend not supportive. RSI neutral at 41. OFD pattern: +SLN (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -4.80% (CS: 4) | Weak |
| RSI_14 | 41.0 | Neutral |
| MACD Histogram | -0.10 | Bearish |
| vs SMA20 | 0.950x | Below |
| vs SMA50 | 0.928x | Below |
| vs SMA200 | 0.926x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $14.18
- **Stop Loss:** $13.04 (8.0% risk)
- **Target:** $15.32 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 789
- **Position Value:** $11,188.02
- **Portfolio %:** 11.19%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with improving risk appetite. VIX decline to 52-week lows and moderate breadth recovery suggest calming conditions, though narrow participation indicates selectivity remains key. Positive earnings momentum and AI adoption themes provide fundamental support for quality growth names.*

### Earnings

**Next:** 2026-02-19 (Est: $0.13)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.55 | $0.65 | +17.8% |
| 2025Q2 | $0.43 | $0.46 | +7.9% |
| 2025Q1 | $0.05 | $0.14 | +174.6% |
| 2024Q4 | $0.21 | $0.30 | +40.9% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_10*